276 related articles for article (PubMed ID: 17907058)
21. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
Ohnaka K; Takayanagi R
Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.
Schlienger N; Lund BW; Pawlas J; Badalassi F; Bertozzi F; Lewinsky R; Fejzic A; Thygesen MB; Tabatabaei A; Bradley SR; Gardell LR; Piu F; Olsson R
J Med Chem; 2009 Nov; 52(22):7186-91. PubMed ID: 19856921
[TBL] [Abstract][Full Text] [Related]
23. Low testosterone in ageing men: a modifiable risk factor for frailty?
O'Connell MD; Ravindrarajah R; Tajar A; Wu FC
Trends Endocrinol Metab; 2011 Dec; 22(12):491-8. PubMed ID: 21978496
[TBL] [Abstract][Full Text] [Related]
24. [Testosterone and male osteoporosis].
Jin JL; Tian CG
Zhonghua Nan Ke Xue; 2002; 8(2):145-7. PubMed ID: 12479035
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometry of selective androgen receptor modulators.
Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery.
Segal S; Narayanan R; Dalton JT
Expert Opin Investig Drugs; 2006 Apr; 15(4):377-87. PubMed ID: 16548787
[TBL] [Abstract][Full Text] [Related]
27. Selective androgen receptor modulators as function promoting therapies.
Bhasin S; Jasuja R
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):232-40. PubMed ID: 19357508
[TBL] [Abstract][Full Text] [Related]
28. Androgens and puberty.
Hiort O
Best Pract Res Clin Endocrinol Metab; 2002 Mar; 16(1):31-41. PubMed ID: 11987896
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
30. [Age-dependent decrease in plasma androgens, and role of androgens in bone mineral density and bone metabolism].
Adachi M; Takayanagi R
Clin Calcium; 2006 Mar; 16(3):419-27. PubMed ID: 16508123
[TBL] [Abstract][Full Text] [Related]
31. Testosterone and frailty.
Morley JE; Kaiser FE; Sih R; Hajjar R; Perry HM
Clin Geriatr Med; 1997 Nov; 13(4):685-95. PubMed ID: 9354749
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
[TBL] [Abstract][Full Text] [Related]
33. Deciphering the selective androgen receptor modulators paradigm.
Zhang X; Sui Z
Expert Opin Drug Discov; 2013 Feb; 8(2):191-218. PubMed ID: 23231475
[TBL] [Abstract][Full Text] [Related]
34. [Role of androgen in the elderly. Current status of development of selective androgen receptor modulator].
Yanase T
Clin Calcium; 2013 Aug; 23(8):1171-7. PubMed ID: 23892218
[TBL] [Abstract][Full Text] [Related]
35. One and the same androgen for all? Towards designer androgens.
Gooren LJ; Nguyen NT
Asian J Androl; 1999 Jun; 1(1-2):21-8. PubMed ID: 11225900
[TBL] [Abstract][Full Text] [Related]
36. Lead evaluation of tetrahydroquinolines as nonsteroidal selective androgen receptor modulators for the treatment of osteoporosis.
Nagata N; Furuya K; Oguro N; Nishiyama D; Kawai K; Yamamoto N; Ohyabu Y; Satsukawa M; Miyakawa M
ChemMedChem; 2014 Jan; 9(1):197-206. PubMed ID: 24273094
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.
Gao W; Kim J; Dalton JT
Pharm Res; 2006 Aug; 23(8):1641-58. PubMed ID: 16841196
[TBL] [Abstract][Full Text] [Related]
38. Selective androgen receptor modulators--prospects for emerging therapy in osteoporosis?
Ke HZ; Wang XN; O'Malley J; Lefker B; Thompson DD
J Musculoskelet Neuronal Interact; 2005; 5(4):355. PubMed ID: 16340136
[No Abstract] [Full Text] [Related]
39. Analysis of the growing public interest in selective androgen receptor modulators.
Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement Up-to-date. The effect of androgen replacement therapy on bone metabolism].
Miyagawa Y; Tsujimura A; Matsuoka Y; Okuyama A
Clin Calcium; 2007 Sep; 17(9):1372-7. PubMed ID: 17767026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
